Robert Cooper

734 total citations
21 papers, 540 citations indexed

About

Robert Cooper is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Robert Cooper has authored 21 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Epidemiology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robert Cooper's work include Muscle Physiology and Disorders (3 papers), Exercise and Physiological Responses (3 papers) and Inflammatory Myopathies and Dermatomyositis (3 papers). Robert Cooper is often cited by papers focused on Muscle Physiology and Disorders (3 papers), Exercise and Physiological Responses (3 papers) and Inflammatory Myopathies and Dermatomyositis (3 papers). Robert Cooper collaborates with scholars based in United Kingdom, United States and Australia. Robert Cooper's co-authors include Adam P. Lightfoot, Edwin Cohen, William H. Beierwaltes, Salil D. Sarkar, Rodney D. Ice, Daniel J. Owens, Jonathan Tang, Adam P. Sharples, Claire E. Stewart and Timothy F. Donovan and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

Robert Cooper

20 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Cooper United Kingdom 11 157 125 116 105 87 21 540
Michael Madsen Denmark 15 231 1.5× 65 0.5× 84 0.7× 163 1.6× 71 0.8× 32 596
Luke A. Beggs United States 12 159 1.0× 41 0.3× 109 0.9× 73 0.7× 34 0.4× 15 402
Jarmo Toivanen Finland 10 114 0.7× 25 0.2× 141 1.2× 199 1.9× 88 1.0× 14 601
Sarah Kim Australia 13 54 0.3× 50 0.4× 130 1.1× 99 0.9× 39 0.4× 19 502
María José Acuña Chile 14 66 0.4× 46 0.4× 386 3.3× 170 1.6× 55 0.6× 22 714
Asako Katsume Japan 11 38 0.2× 93 0.7× 373 3.2× 262 2.5× 129 1.5× 13 806
Julian Meyer Berger United States 7 58 0.4× 50 0.4× 194 1.7× 148 1.4× 40 0.5× 11 514
Timothy M. Moore United States 14 44 0.3× 66 0.5× 251 2.2× 169 1.6× 31 0.4× 22 609
Antonis Halapas Greece 11 61 0.4× 34 0.3× 142 1.2× 57 0.5× 50 0.6× 13 364
Haimin Xu China 10 54 0.3× 97 0.8× 191 1.6× 168 1.6× 31 0.4× 44 667

Countries citing papers authored by Robert Cooper

Since Specialization
Citations

This map shows the geographic impact of Robert Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Cooper more than expected).

Fields of papers citing papers by Robert Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Cooper. The network helps show where Robert Cooper may publish in the future.

Co-authorship network of co-authors of Robert Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Cooper. A scholar is included among the top collaborators of Robert Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Cooper. Robert Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hacking, Sean, et al.. (2024). A novel approach correlating pathologic complete response with digital pathology and radiomics in triple-negative breast cancer. Breast Cancer. 31(3). 529–535. 5 indexed citations
2.
Garg, Harshit, Philip Whalen, Robert Cooper, et al.. (2023). Patency outcomes of primary inferior vena cava repair in radical nephrectomy and tumor thrombectomy. Journal of Vascular Surgery Venous and Lymphatic Disorders. 11(3). 595–604.e2. 2 indexed citations
4.
Cotton, Caroline, Lisa Spencer, Robert P New, & Robert Cooper. (2016). The utility of comprehensive autoantibody testing to differentiate connective tissue disease associated and idiopathic interstitial lung disease subgroup cases. Lara D. Veeken. 56(8). kew320–kew320. 7 indexed citations
5.
Lightfoot, Adam P. & Robert Cooper. (2016). The role of myokines in muscle health and disease. Current Opinion in Rheumatology. 28(6). 661–666. 65 indexed citations
6.
Lightfoot, Adam P., Kanneboyina Nagaraju, Anne McArdle, & Robert Cooper. (2015). Understanding the origin of non-immune cell-mediated weakness in the idiopathic inflammatory myopathies – potential role of ER stress pathways. Current Opinion in Rheumatology. 27(6). 580–585. 29 indexed citations
7.
Naclerio, Fernando, Eneko Larumbe‐Zabala, Robert Cooper, Judith Allgrove, & Conrad P. Earnest. (2015). A Multi-Ingredient Containing Carbohydrate, Proteins L-Glutamine and L-Carnitine Attenuates Fatigue Perception with No Effect on Performance, Muscle Damage or Immunity in Soccer Players. PLoS ONE. 10(4). e0125188–e0125188. 26 indexed citations
8.
Owens, Daniel J., Adam P. Sharples, Timothy F. Donovan, et al.. (2015). A systems-based investigation into vitamin D and skeletal muscle repair, regeneration, and hypertrophy. American Journal of Physiology-Endocrinology and Metabolism. 309(12). E1019–E1031. 108 indexed citations
10.
Thompson, Ben, et al.. (2008). Alemtuzumab (Campath-1H) for treatment of refractory polymyositis.. PubMed. 35(10). 2080–2. 24 indexed citations
11.
Pantanowitz, Liron, et al.. (2007). Cholesterol crystals in the thyroid gland.. PubMed. 51(2). 249–51. 2 indexed citations
12.
Soop, Mattias, Martin Gibson, Stephen J. Hopkins, et al.. (2002). Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. American Journal of Physiology-Endocrinology and Metabolism. 282(6). E1276–E1285. 94 indexed citations
13.
Cooper, Robert, Yasmin Khakoo, Katherine K. Matthay, et al.. (2001). Opsoclonus‐myoclonus‐ataxia syndrome in neuroblastoma: Histopathologic features–A report from the children's cancer group. Medical and Pediatric Oncology. 36(6). 623–629. 2 indexed citations
14.
Davies, Peter R., et al.. (2000). Tc-99m Sestamibi Uptake in Metastatic Prostate Carcinoma. Clinical Nuclear Medicine. 25(2). 133–133. 1 indexed citations
16.
Hain, Richard, David Chitayat, Robert Cooper, et al.. (1994). Hb FM-Fort Ripley: Confirmation of autosormal dominant inheritance and diagnosis by PCR and direct nucleotide sequencing. Human Mutation. 3(3). 239–242. 10 indexed citations
17.
Cooper, Robert, María Stokes, & R. H. T. Edwards. (1989). Myofibrillar activation failure in McArdle's disease. Journal of the Neurological Sciences. 93(1). 1–10. 15 indexed citations
18.
19.
Sarkar, Salil D., et al.. (1977). A New and Superior Adrenal Imaging Agent,131I-6ß-Iodomethyl-19-Nor-Cholesterol (NP-59): Evaluation in Humans. The Journal of Clinical Endocrinology & Metabolism. 45(2). 353–362. 69 indexed citations
20.
Bass, Bernard M., Robert Cooper, & J. A. Haas. (1970). Managing for accomplishment. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026